EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints

Philippe Sultanik, Lyes Kheloufi, Apolline Leproux, Charlotte Bouzbib, Sarah Mouri, Antoine Santiago, Damien Galanaud, Vincent Navarro, Mehdi Sakka, Marika Rudler, Nicolas Weiss iD, Dominique Thabut iD

Alimentary Pharmacology & Therapeutics · 2024-09 · 60 (6) · 749-764

DOI: 10.1111/apt.18148 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2024-07-07. Written by Philippe Sultanik and 11 co-authors. Institution: Liver Intensive Care Unit, Hepatogastroenterology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France. Major MEDLINE topics: Hepatic Encephalopathy, Liver Cirrhosis, Neuropsychological Tests, Cognitive Dysfunction. Cited 13 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background/Aims Although it is well admitted that cirrhotic patients display various causes of neurocognitive impairment (NI) hampering the diagnosis of covert hepatic encephalopathy (CHE), those are almost never investigated per se. The aims of this study were, in cirrhotic patients displaying cognitive complaints explored by a complete multimodal work‐up, to assess: (1) the prevalence of CHE and/or that of other causes of NI and (2) their outcomes, according to the cause of NI.

Methods

Prospective cohort of cirrhotic patients referred in a dedicated clinic because of cognitive complaints. Work‐up included a complete neuropsychological assessment, electroencephalogram (EEG) and brain magnetic resonance imaging with spectroscopy. The diagnosis of CHE was made by an adjudication committee involving the physicians/neuropsychologist.

Results

One hundred and twenty‐three patients were included (alcohol/MASLD/virus in 63/53/14%, MELD = 11). Sixty‐six per cent of them were diagnosed with CHE; among them, 73% exhibited also other causes of NI, mainly cerebrovascular diseases/psychiatric. Among patients without CHE, 48% and 59% displayed pathological Psychometric Hepatic Encephalopathy Score and animal naming test, respectively. Clinical improvement was observed in 77% of the patients re‐evaluated after specific management. CHE, but not the other causes of NI, was independently associated with OHE occurrence.

Conclusion

Other causes of NI than CHE are frequent in patients with cirrhosis, and not ruled‐out by the classical tests dedicated to CHE. Prognosis was influenced by the cause of NI. The management of patients even without CHE led to clinical improvement, underlining the need for a multifaceted approach of cirrhotic patients with cognitive complaints.

Subjects

MeSH terms (MEDLINE)

Hepatic EncephalopathyLiver CirrhosisNeuropsychological TestsCognitive DysfunctionHumansMaleFemaleMiddle AgedProspective StudiesAgedElectroencephalographyMagnetic Resonance ImagingAdultPrevalence

Authors and institutions

  • Liver Intensive Care Unit, Hepatogastroenterology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • Brain-Liver Pitié-Salpêtrière Study Group (BLIPS), Paris, France.
  • INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
  • Neuroradiology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • Neurology Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • Biochemistry Department, La Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.

ORCID profiles: Nicolas Weiss, Dominique Thabut

Cite

APA

Sultanik, P., Kheloufi, L., Leproux, A., Bouzbib, C., Mouri, S., Santiago, A., Galanaud, D., Navarro, V., Sakka, M., Rudler, M., Weiss, N., & Thabut, D. (2024). Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints. Alimentary Pharmacology & Therapeutics, 60(6), 749-764. https://doi.org/10.1111/apt.18148

Vancouver

Sultanik P, Kheloufi L, Leproux A, Bouzbib C, Mouri S, Santiago A, et al. Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints. Alimentary Pharmacology & Therapeutics. 2024;60(6):749-764. doi:10.1111/apt.18148

BibTeX
@article{Sultanik2024,
  author = {Sultanik, Philippe and Kheloufi, Lyes and Leproux, Apolline and Bouzbib, Charlotte and Mouri, Sarah and Santiago, Antoine and Galanaud, Damien and Navarro, Vincent and Sakka, Mehdi and Rudler, Marika and Weiss, Nicolas and Thabut, Dominique},
  title = {Other causes of neurocognitive impairment than covert hepatic encephalopathy ( CHE ) are very frequent, either alone or associated with CHE , in cirrhotic patients with cognitive complaints},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  volume = {60},
  number = {6},
  pages = {749--764},
  doi = {10.1111/apt.18148}
}
Start for free →